The PDGFRβ CMML Test is a specialized diagnostic assay designed to detect genetic abnormalities associated with Chronic Myelomonocytic Leukemia (CMML), a type of cancer that affects the blood and bone marrow. This test specifically looks for mutations or rearrangements in the platelet-derived growth factor receptor beta (PDGFRβ) gene, which can play a significant role in the development and progression of CMML. Identifying these genetic markers is crucial for determining the most effective treatment strategy for patients.
The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing capabilities. The cost of the PDGFRβ CMML Test at DNA Labs UAE is 1050 AED. This investment in diagnostic testing is vital for patients suspected of having CMML, as it provides essential information that can guide personalized treatment plans, potentially leading to better outcomes.
The PDGFRα HES Test, available at DNA Labs UAE for a cost of 1050 AED, is a diagnostic tool designed to identify mutations in the platelet-derived growth factor receptor alpha (PDGFRα) gene. These mutations are often associated with hypereosinophilic syndrome (HES), a group of blood disorders characterized by the overproduction of eosinophils, a type of white blood cell. By detecting specific genetic abnormalities in the PDGFRα gene, this test helps in the diagnosis and management of HES, enabling healthcare providers to tailor treatment strategies effectively. Conducted in the state-of-the-art facilities of DNA Labs UAE, the PDGFRα HES Test is a crucial step towards personalized medicine for patients suffering from this complex condition.
PMLRARA AML - M3 APML Test is a specialized diagnostic procedure aimed at detecting the presence of the PML/RARA fusion gene, which is indicative of Acute Promyelocytic Leukemia (APML), a subtype of Acute Myeloid Leukemia (AML). This test is crucial for the accurate diagnosis and management of APML, as the presence of the PML/RARA gene fusion plays a key role in the disease's pathogenesis and influences treatment strategies. Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic technologies and expertise, the test ensures reliable results. The cost for undergoing the PMLRARA AML - M3 APML Test at DNA Labs UAE is set at 1050 AED, reflecting the comprehensive approach and precise analysis involved in identifying this critical genetic marker.
The "PMLRARA Qualitative BCR 1 and 3 Test" is a specialized diagnostic examination aimed at detecting the presence of the PML/RARA fusion gene, which is a hallmark of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). This genetic anomaly arises from the translocation between chromosomes 15 and 17, leading to the creation of the PML/RARA fusion gene. The test specifically looks for breakpoints in BCR 1 and BCR 3, which are critical regions affecting the gene's function and the disease's clinical outcome.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves collecting a sample of the patient's blood or bone marrow. The laboratory utilizes sophisticated molecular techniques to qualitatively assess the presence of the PML/RARA fusion gene, providing crucial information for the diagnosis, prognosis, and treatment planning of individuals suspected of having APL.
The cost of the "PMLRARA Qualitative BCR 1 and 3 Test" at DNA Labs UAE is set at 1050 AED. This price reflects the intricate nature of the testing process and the significant impact its results have on the management of patients with acute promyelocytic leukemia. Early detection and confirmation of the PML/RARA fusion gene enable healthcare providers to initiate targeted therapies, significantly improving patient outcomes.
Prader-Willi Syndrome (PWS) is a rare genetic disorder characterized by a range of physical, mental, and behavioral problems including chronic hunger, poor muscle tone, and developmental delays. To accurately diagnose this condition, the Prader-Willi Syndrome FISH (Fluorescence In Situ Hybridization) test is employed, which is a sophisticated genetic test designed to detect abnormalities specific to the chromosome 15 region associated with PWS.
The FISH test involves using fluorescent probes that bind to specific parts of chromosomes, making it possible to visualize genetic abnormalities under a microscope. This method is highly effective in identifying the deletion or uniparental disomy (UPD) of chromosome 15, which are common genetic markers of Prader-Willi Syndrome.
In the United Arab Emirates, DNA Labs UAE is a reputable facility that offers the Prader-Willi Syndrome FISH Test. The test is priced at 1050 AED, providing a crucial diagnostic tool for families and physicians dealing with the potential diagnosis of PWS. The results from this test can help in planning appropriate management and therapeutic strategies for individuals diagnosed with Prader-Willi Syndrome, ultimately improving their quality of life.
Replication Factor C1 Mutation Screening (RFC1 - 80G>A Test) is a specialized genetic test offered by DNA Labs UAE, designed to identify mutations in the RFC1 gene, specifically the 80G>A mutation. This mutation can have significant implications for cellular DNA replication and repair mechanisms, potentially leading to various genetic disorders or influencing the risk of developing certain diseases. The test involves analyzing the individual's DNA to detect the presence of the 80G>A mutation in the RFC1 gene, providing valuable insights into genetic health and predispositions. Priced at 1050 AED, this test is a crucial tool for individuals seeking a deeper understanding of their genetic makeup, particularly those with a family history of genetic disorders linked to the RFC1 gene. By identifying this mutation, healthcare providers can offer personalized medical advice, preventive measures, or targeted treatments to manage or mitigate associated health risks.
The "15-20 Slide and Block Test" offered by DNA Labs UAE is a comprehensive diagnostic assessment designed to analyze a specific range of biological samples. This test, priced at 1050 AED, is meticulously carried out in the state-of-the-art facilities of DNA Labs UAE, a reputable institution known for its advanced diagnostic and research capabilities. The test involves the detailed examination of 15 to 20 slides or blocks, which could encompass a variety of sample types depending on the diagnostic requirement. This could include tissues, cells, or other biological materials that need in-depth analysis for medical, research, or forensic purposes.
DNA Labs UAE employs cutting-edge technology and follows stringent protocols to ensure the accuracy and reliability of the test results. The process involves preparing the slides or blocks, followed by a detailed microscopic examination and analysis by highly qualified and experienced professionals. This test is crucial for diagnosing diseases, understanding pathological conditions, or for academic and research purposes, providing invaluable insights into the sample's microscopic structure and function.
Given its comprehensive nature and the expertise involved, the test cost of 1050 AED is justified, offering clients access to world-class diagnostic services. DNA Labs UAE also ensures confidentiality and timely delivery of test results, making it a preferred choice for individuals and professionals seeking detailed and reliable analysis.
Sickle Cell Disease Mutation Screening Test is a crucial diagnostic tool offered at DNA Labs UAE, aimed at identifying the presence of mutations in the HBB gene, which are responsible for sickle cell disease (SCD). This genetic condition affects the shape and functionality of red blood cells, leading to various health complications such as pain, infections, and anemia. The test, priced at 1050 AED, involves analyzing a sample of the patient's DNA to detect specific mutations linked to SCD. This screening is particularly beneficial for individuals with a family history of the disease or those belonging to regions where the condition is prevalent. By providing early detection, the Sickle Cell Disease Mutation Screening Test enables timely interventions and informed decisions about managing the condition, thereby improving the quality of life for those affected.
The "Small Biopsy Bottle No 10 Test" is a specific diagnostic procedure available at DNA Labs UAE, designed to analyze small biopsy samples for a variety of medical purposes. This test involves collecting a small tissue sample from the patient, which is then securely placed in a designated biopsy bottle, labeled as No 10, for precise handling and analysis. The procedure is critical for diagnosing diseases, understanding the extent of tissue abnormality, and guiding treatment plans.
DNA Labs UAE, a reputable laboratory known for its advanced diagnostic services, offers this test for a cost of 1050 AED. The laboratory utilizes state-of-the-art technology and employs highly skilled professionals to ensure accurate and reliable results. Patients opting for the Small Biopsy Bottle No 10 Test at DNA Labs UAE can expect a thorough examination of their biopsy sample, contributing to effective disease management and treatment decisions.
The "TELAML ALL Test" is a specialized diagnostic procedure designed to identify the TEL-AML1 gene fusion, which is commonly associated with acute lymphoblastic leukemia (ALL). This genetic anomaly is crucial for the diagnosis, prognosis, and management of ALL, a type of cancer that affects the white blood cells and can progress rapidly if left untreated. The test involves analyzing the patient's DNA to detect the presence of the TEL-AML1 fusion gene, which can influence treatment decisions and help predict the patient's response to therapy.
Performed at DNA Labs UAE, a reputable facility known for its advanced diagnostic technologies and expert staff, the test ensures accuracy and reliability. The cost of the TELAML ALL Test is set at 1050 AED, making it a valuable investment for individuals seeking comprehensive insights into their health status concerning acute lymphoblastic leukemia. By opting for this test at DNA Labs UAE, patients and healthcare providers can access crucial genetic information that plays a significant role in tailoring treatment strategies for optimal outcomes.
